Wallbox Plan Accepted by NYSE, Gains Six-Month Cure Period for $1 Minimum Bid
WBX•Wallbox received NYSE acceptance of its plan to regain compliance with continued listing standards after failing to meet the $1 per share minimum bid price rule, avoiding delisting risk. The company now has six months to achieve a sustained $1 per share closing price over 30 consecutive trading days.
1. NYSE Acceptance of Compliance Plan
Wallbox received notification from the NYSE that its submitted compliance plan has been approved, addressing the breach of the exchange’s minimum $1 per share average bid price rule. This acceptance maintains Wallbox’s listing status and prevents immediate delisting procedures.
2. Cure Period and Requirements
The exchange has granted Wallbox a six-month cure period to achieve a sustained $1 per share closing price over at least 30 consecutive trading days. Failure to meet this requirement by the deadline will trigger delisting steps under NYSE rules.
3. Potential Risks and Investor Impact
Investors should note that while listing status is secure for now, share price performance remains critical and market volatility could affect chances of compliance. Successful execution of this plan may restore confidence, but any renewed price weakness could reopen delisting concerns.
